Sentences with phrase «developing macular»

Zinc protects the retina and lowers the risk of developing macular degeneration.

Exposure to cigarette smoke doubles your risk of developing macular degeneration, a leading cause of blindness.

There is no cure for macular degeneration (or for glaucoma), yet there are some basic things you can do to help prevent developing macular degeneration, and to possibly slow the progression of it if you already have it.

Dates provide fiber, iron, potassium and B - vitamins, an lutein and zeaxanthin which is needed for protecting the eyes from developing macular degenration.

Each year, around 2.5 million people worldwide develop macular degeneration and it is the commonest cause of blindness in industrialised countries.

Also, a 2009 National Eye Institute (NEI) study that used data obtained from the Age - Related Eye Disease Study (AREDS) found participants who reported the highest level of omega - 3 fatty acids in their diet were 30 percent less likely than their peers to develop macular degeneration during a 12 - year period.

Smokers are up to four times more likely to develop macular degeneration than people who have never smoked.

However, having developed macular degeneration, I find I can no longer read my printed treasures... the sole and only reason for my existence!

Not exact matches

The risk of developing age - related macular degeneration is much less in the Baby Boom (1946 - 1964) and later generations than in earlier generations, for unclear reasons.

According to a smaller study, running also reduces the risk of macular degeneration — the leading cause of blindness in developed countries.

Advanced Cell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastocyst.

Peter Coffey, a stem - cell biologist at the Institute of Ophthalmology in London, is developing an embryonic - stem - cell treatment for macular degeneration with the global drug company Pfizer.

For now, the HapMap project does not mean new genetic tests for diseases are about to appear, but at least one company is considering whether to develop a test for genetic vulnerability to macular degeneration.

«It's fantastic news that they are going into the clinic with a cell therapy for eye disease,» says Pete Coffey of University College London, and head of a team developing tiny «patches» of RPEs for treating age - related macular degeneration.

This is the case with age - related macular degeneration — a «wet» version of which causes vision loss in the center of the eye — and diabetic retinopathy — in which some people with diabetes develop blurry or patchy vision.

During a 24 - month clinical trial, Colby (and fellow ophthalmologists David Chang of the University of California, San Francisco, Doyle Stulting of Emory University's Eye Center in Atlanta, and Stephen S. Lane of Associated Eye Care in Stillwater, Minn.) developed and tested a preferred technique for implanting the device to most effectively treat bilateral end - stage macular degeneration, which most commonly afflicts people over the age of 55.

In fact, although only 10 percent of patients develop new blood vessels, this complication is responsible for most of the legal blindness associated with macular degeneration.

There may be a connection between taking vasodilators and developing early - stage age - related macular degeneration (AMD), the leading cause of vision loss and blindness among Americans who are age 65 and older, according to a study published online in Ophthalmology, the journal of the American Academy of Ophthalmology.

Researchers at Massachusetts Eye and Ear / Harvard Medical School and the University of Crete have conducted a phase I / II clinical trial investigating the efficacy of statins (cholesterol - lowering medications) for the treatment of patients with the dry form of age - related macular degeneration (AMD)-- the leading cause of blindness in the developed world.

They have joined forces with CHS Pharma, Inc., a South Florida - based biotechnology development company that has an intellectual property portfolio for potential treatments related to ischemic stroke, dry macular degeneration as well as other age - related disorders such as Alzheimer's disease, to further develop and commercialize this promising technology.

A team led by Steven Schwartz at UCLA administered about 50,000 cells Tuesday into one eye of a volunteer suffering from Stargardt Macular Dystrophy, a progressive form of blindness that usually begins in childhood, and another with Dry Age - Related Macular Degeneration, the leading cause of blindness in the developed world, Advanced Cell Technology, which is sponsoring the study, announced Thursday.

A team of researchers at the University of Southern California grew stem - cell membranes in a sterile lab for a month and then inserted them into the eyes of four people with «dry» macular degeneration, the leading cause of blindness in developed countries.

Leading scientists from around the world will begin research projects to prevent inflammation, better understand advanced macular degeneration, and develop new treatments for patients.

BrightFocus supports U.S. domestic and international research proposals related to developing treatments, preventions, and cures for glaucoma, macular degeneration, and Alzheimer's disease.

Our findings open the way to develop therapeutic strategies to remove lipofuscin from RPE cells, which may have implications for the treatment of age - related macular degeneration in which lipofuscin accumulation in cells is a causative factor.

BrightFocus accepts investigator initiated proposals related to developing treatments, preventions, and cures for glaucoma, macular degeneration, and Alzheimer's disease.

His work, involving stem cell technology, will help drive forward efforts to understand and develop therapies for macular degeneration, one of the most significant causes of morbidity in the elderly.

Macular degeneration is a leading cause of blindness among the older population of the USA and other developed countries.

Age - related macular degeneration (AMD) is the most common cause of legal blindness in the elderly in developed countries, and is a leading cause of blindness worldwide.

Age - related macular degeneration is one of the most common causes of vision loss in developed countries, affecting between 30 million and 50 million people worldwide.

We understand now that most of the risk for developing age - related macular degeneration (AMD) comes from environmental causes, particularly our diets and nutrition; however, we don't know why these dietary factors change the risk of AMD or how they affect our bodies.

In my own lab here at Indiana University School of Medicine, I am bringing some of those chemical biology techniques to bear on problems in eye disease and we continue to work on tumors of the eye, but we also developed a major focus on neovascular eye diseases, including wet, age - related macular degeneration (AMD).

Bionic Vision Australia is a national consortium of researchers working together to develop a bionic eye to restore vision to people with retinitis pigmentosa and age - related macular degeneration.

The goal of the project is to develop a novel therapy that can overcome the problems associated with the current anti-VEGF therapy for wet age - related macular degeneration (AMD), a leading cause of blindness in the elderly.

The goal of the project is to define microRNA mechanism in age - related macular degeneration (AMD) and develop novel microRNA - based AMD therapeutics.

Paulaitis says «the novel concepts put forth in this study, of investigating small molecules called microRNAs to see what they can tell us about mitochondria disorders in cells of the retina, hold great promise of providing new insights into how age - related macular degeneration develops, after which new treatments can be designed to save or improve vision.»

Leafy greens like spinach, kale and turnip and collard greens are famous for being an excellent source of lutein and zeaxanthin, antioxidants that prevent macular degeneration and decrease the risk of developing non-Hodgkin's lymphoma.

(MASTERFILE) Cathy Lowery, 50, of Western Springs, Ill., says her mother was doing fine in her assisted living home until she developed age - related macular degeneration (AMD), a condition that causes severely blurred vision or blindness.

In recent studies, the phytochemicals, lutein and zeaxanthin, have shown to reduce the risk of developing AMD or age - related macular - degeneration.

You may also be more likely to develop age - related macular degeneration or neurological disorders like attention - deficit hyperactivity disorder.

Kale contains compounds called glucosinolates that may help prevent cancer, plus lutein and zeaxanthin, which are related to vitamin A and may help lower your risk of developing cataracts and macular degeneration.

Lutein and zeaxanthin may lower your chance of developing age - related problems such as macular degeneration and cataracts.

For their upcoming group show at Wood Street Galleries, members of the Dutch art collective Macular have developed four kinetic light installations.